JIR
MGCD

James Investment Research’s MGC Diagnostics Corporation MGCD Stock Holding History

James Investment Research’s Portfolio MGCD Stock Details MGCD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,091
Closed -$12K – 875
2017
Q4 		$12K Hold
1,091
– – ﹤0.01% 735
2017
Q3 		$10K Hold
1,091
– – ﹤0.01% 721
2017
Q2 		$9K Hold
1,091
– – ﹤0.01% 692
2017
Q1 		$9K Hold
1,091
– – ﹤0.01% 626
2016
Q4 		$9K Buy
+1,091
New +$8.15K ﹤0.01% 500

James Investment Research's MGCD Position: Q1 2018 in Review

James Investment Research sold out of MGC Diagnostics Corporation (MGCD) in Q1 2018, closing a stake of 1,091 shares — an estimated $12K sold.

James Investment Research first reported a position in MGCD in Q4 2016 and held it in 5 quarters. The position peaked at $12K in Q4 2017. 0 funds tracked by Wall St. Rank hold MGCD as of Q1 2018.

  • James Investment Research reported no remaining MGC Diagnostics Corporation position as of Q1 2018 after selling out during the quarter.
  • James Investment Research sold 1,091 MGC Diagnostics Corporation shares in Q1 2018, an estimated $12K.
  • James Investment Research first reported a position in MGC Diagnostics Corporation in Q4 2016 and held it in 5 quarters.
  • James Investment Research's MGC Diagnostics Corporation position peaked at $12K in Q4 2017.
  • 0 funds tracked by Wall St. Rank held MGC Diagnostics Corporation as of Q1 2018.

Based on James Investment Research's 13F filing for Q1 2018, filed 12 Apr 2018.